Medigene (MDGEF) News Today $1.30 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell EngagersDecember 9, 2024 | globenewswire.comMedigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021September 25, 2024 | globenewswire.comMedigene AG Secures Two Additional Patents for Technologies in Its End-to-End PlatformAugust 29, 2024 | globenewswire.comMedigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024August 26, 2024 | globenewswire.comQ2 2024 Medigene AG Earnings Call TranscriptAugust 15, 2024 | gurufocus.comMedigene AG (MDGEF) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...August 15, 2024 | gurufocus.comMedigene AG Reports Half-Year 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | globenewswire.comMedigene AG to Report Half-Year 2024 Financial Results on August 14, 2024August 8, 2024 | globenewswire.comMedigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in ChinaJuly 3, 2024 | globenewswire.comMedigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent OfficeMay 28, 2024 | globenewswire.comMedigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital RaiseMay 14, 2024 | globenewswire.comMedigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell ReceptorMay 2, 2024 | globenewswire.comMedigene AG reports Financial Results and Business Update for Q1 2024April 26, 2024 | globenewswire.comMedigene AG Secures European Patent for its iM-TCR TechnologyApril 4, 2024 | globenewswire.comMedigene AG Reports Full-Year 2023 Financial Results and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comMedigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceMarch 19, 2024 | globenewswire.comMedigene AG to report full year 2023 financial results on March 28, 2024March 18, 2024 | globenewswire.comMedigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In VivoMarch 4, 2024 | globenewswire.com Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGEF and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol MDGEF Media Mentions By Week MDGEF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGEF News Sentiment▼0.000.60▲Average Medical News Sentiment MDGEF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGEF Articles This Week▼00▲MDGEF Articles Average Week Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGEF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MDGEF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Medigene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDGEF Stock Alerts